Man Group PLC Standard Biotools Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Man Group PLC holds 12,913 shares of LAB stock, worth $21,952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,913
Previous 310,604
95.84%
Holding current value
$21,952
Previous $841,000
97.38%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LAB
# of Institutions
150Shares Held
265MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$109 Million9.76% of portfolio
-
Viking Global Investors LP58.7MShares$99.7 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$29.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$22 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $134M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...